Brief: Medigene Strengthens Its Patent Portfolio With US Patent On Tagged TCR
Feb 1 (Reuters) - MEDIGENE AG MDG1k.DE :
* MEDIGENE STRENGTHENS ITS PATENT PORTFOLIO WITH A US PATENT
ON A
TAGGED TCR
Source text for Eikon: ID:nPex0Kx36a
Further company coverage: MDG1k.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million